menu
    • menu

    Company profile for Theriva Biologics

    NEW Drugs in Dev: 8
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Theriva Biologics is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. Our therapies are designed to enable systemic delivery and have the potential to enhance current standard-of-care therapies, offering patients with difficult-to-treat cancers the chance of a longer life. Led by a team of experienced ...
    Theriva Biologics is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. Our therapies are designed to enable systemic delivery and have the potential to enhance current standard-of-care therapies, offering patients with difficult-to-treat cancers the chance of a longer life. Led by a team of experienced leaders with a vision for clinical innovation, we are committed to offering new therapeutic modalities that improve the way cancer is treated.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Theriva BiologicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850
    Telephone
    Telephone
    (301) 417-4364
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://therivabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/theriva-biologics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/TOVXBiologics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Food Ingredients China

    Not Confirmed

    envelop Contact Supplier

    Food Ingredients China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theriva Biologics Unveils 2025 Operational Highlights & Results
    Theriva Biologics Unveils 2025 Operational Highlights & Results

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254568/0/en/Theriva-Biologics-Reports-Full-Year-2025-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Theriva Biologics Licenses SYN-020 to Rasayana
    Theriva Biologics Licenses SYN-020 to Rasayana

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240133/0/en/Theriva-Biologics-Licenses-SYN-020-to-Rasayana-Therapeutics-for-Multiple-Indications.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Theriva Biologics To Present VCN-01 Retinoblastoma Trial Data
    Theriva Biologics To Present VCN-01 Retinoblastoma Trial Data

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231020/0/en/Theriva-Biologics-Announces-Upcoming-Presentation-of-Data-from-VCN-01-Retinoblastoma-Phase-1-Clinical-Trial-at-APAO-2026.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Theriva Receives Positive EMA Advice on VCN-01 PDAC Trial Design
    Theriva Receives Positive EMA Advice on VCN-01 PDAC Trial Design

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210890/0/en/Theriva-Biologics-Announces-Positive-Scientific-Advice-from-the-European-Medicines-Agency-EMA-on-the-Design-of-a-Phase-3-Trial-of-VCN-01-in-Metastatic-Pancreatic-Ductal-Adenocarcin.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Theriva Biologics Unveils Q3 2025 Operations Highlights & Results
    Theriva Biologics Unveils Q3 2025 Operations Highlights & Results

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186207/0/en/Theriva-Biologics-Reports-Third-Quarter-2025-Operational-Highlights-and-Financial-Results.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Theriva Biologics Provides Response To Unusual Market Action
    Theriva Biologics Provides Response To Unusual Market Action

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3173023/0/en/Theriva-Biologics-Provides-Response-to-Unusual-Market-Action.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search